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Abstract: OBJECTIVES To investigate the dependence of signal-to-noise ratio (SNR) and calculated
average dose per volume of spiral breast-CT (B-CT) on breast size and breast density and to provide
a guideline for choosing the optimal tube current for each B-CT examination. MATERIALS AND
METHODS Three representative B-CT datasets (small, medium, large breast size) were chosen to create
3D-printed breast phantoms. The phantoms were filled with four different agarose-oil-emulsions mimick-
ing differences in breast densities. Phantoms were scanned in a B-CT system with systematic variation
of the tube current (6, 12.5, 25, 32, 40, 50, 64, 80, 100, 125 mA). Evaluation of SNR and the average dose
per volume using Monte Carlo simulations were performed for high (HR) and standard (STD) spatial
resolution. RESULTS SNR and average dose per volume increased with increasing tube current. Arti-
facts had negligible influence on image evaluation. SNR values ฀ 35 (HR) and ฀ 100 (STD) offer sufficient
image quality for clinical evaluation with SNR being more dependent on breast density than on breast
size. For an average absorbed dose limit of 6.5 mGy for the medium and large phantoms and 7 mGy for
the small phantom, optimal tube currents were either 25 or 32 mA. CONCLUSIONS B-CT offers the
possibility to vary the X-ray tube current, allowing image quality optimization based on individual pa-
tient’s characteristics such as breast size and density. This study describes the optimal B-CT acquisition
parameters, which provide diagnostic image quality for various breast sizes and densities, while keeping
the average dose at a level similar to digital mammography. KEY POINTS • Image quality optimization
based on breast size and density varying the tube current using spiral B-CT.
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Abstract
Objectives To investigate the dependence of signal-to-noise ratio (SNR) and calculated average dose per volume of spiral breast-
CT (B-CT) on breast size and breast density and to provide a guideline for choosing the optimal tube current for each B-CT
examination.
Materials and methods Three representative B-CT datasets (small, medium, large breast size) were chosen to create 3D-printed
breast phantoms. The phantoms were filled with four different agarose-oil-emulsions mimicking differences in breast densities.
Phantoms were scanned in a B-CT system with systematic variation of the tube current (6, 12.5, 25, 32, 40, 50, 64, 80, 100, 125
mA). Evaluation of SNR and the average dose per volume using Monte Carlo simulations were performed for high (HR) and
standard (STD) spatial resolution.
Results SNR and average dose per volume increased with increasing tube current. Artifacts had negligible influence on image
evaluation. SNR values ≥ 35 (HR) and ≥ 100 (STD) offer sufficient image quality for clinical evaluation with SNR being more
dependent on breast density than on breast size. For an average absorbed dose limit of 6.5 mGy for the medium and large
phantoms and 7 mGy for the small phantom, optimal tube currents were either 25 or 32 mA.
Conclusions B-CT offers the possibility to vary the X-ray tube current, allowing image quality optimization based on individual
patient’s characteristics such as breast size and density. This study describes the optimal B-CT acquisition parameters, which
provide diagnostic image quality for various breast sizes and densities, while keeping the average dose at a level similar to digital
mammography.
Key Points
• Image quality optimization based on breast size and density varying the tube current using spiral B-CT.
Keywords Spiral CT . Breast cancer .Monte Carlomethod . Radiation dosage . Signal-to-noise ratio
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Worldwide, breast cancer (BC) is not only the most common-
ly diagnosed cancer but also the leading cause of cancer death
among women. In most countries in transition, the incidence
rates of BC have increased during the last decades. The inci-
dence of BC in Europe is among the world’s highest, which is
why the prevention of BC is a major public health concern in
European countries [1].
Breast cancer screening in asymptomatic women has been
shown to reduce BC-related mortality [2, 3]. Although there
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are still some controversies about the overall benefit of BC
screening programs, they exist in most European countries
[4]. Digital two-viewmammography (DM) is the current stan-
dard technique for screening and diagnosis of BC. Besides the
necessity of painful breast compression, a major issue of DM
is the relatively high frequency of false-positive test results,
thus a low specificity. Due to tissue overlapping, the sensitiv-
ity of DM is reduced in dense breasts, which might lead to
small tumors being missed [5, 6]. In addition, breast implants
impede the examination of the breast using DM.
Another possible screening technique is digital breast
tomosynthesis (DBT) which involves acquiring several low-
dose two-dimensional projections by different X-ray tube angles
that are used to reconstruct a specific number of image slices
comparable to conventional tomography. DBT can be conduct-
ed instead or in addition toDM. Reducing the tissue overlapping
effect, its application improves sensitivity and specificity signif-
icantly [7, 8]. DBT offers very high in-plane resolution but due
to a limited rotation angle, only an incomplete set of projections
is obtained resulting in a suboptimal z-axis resolution [9].
Similar to DM, DBT requires breast compression.
More recently, dedicated spiral breast-CT (B-CT) systems
have been introduced and have proved to be a potential alter-
native to DM and DBT. Due to true 3D image acquisition, B-
CT resolution is not only better but also isotropic compared to
DM and DBT without painful breast compression. The use of
photon-counting detector technology offers a resolution of bet-
ter than 100 μm for both in-plane and z-resolution. The tech-
nology allows B-CT to have more efficient dose utilization and
thus reduced radiation dose to levels similar to mammography
and tomosynthesis [10–12]. Initial experience with the clinical
use of a new dedicated B-CTwith photon-counting detector has
shown that it can provide high-quality images which are of
particular value for BC screening and diagnosis.
Unlike other CT systems, the B-CT requires all scan param-
eters to be set before acquiring the datasets. However, detailed
instructions about the choice of the optimal tube current depend-
ing on breast size and density in correlation to the desired signal-
to-noise ratio (SNR) and applied dose were not yet addressed.
The purpose of our study is to systematically evaluate the
influence of breast density, breast size, and X-ray tube current
on SNR and dose levels. Moreover, we aim at providing a table
showing the optimal tube current depending on the individual
breast size and density, which provides optimal image quality
while maintaining sufficient control of the applied average dose.
Materials and methods
Datasets
The retrospective evaluation of the datasets was approved by
the local ethics committee. Patients gave written informed
consent to the retrospective analysis of their data. The image
datasets for 3D-printing were acquired in women referred for
breast cancer screening without pathological findings. The
scans were taken in a prone position using a dedicated spiral
B-CT system (nu:view, AB-CT – Advanced Breast-CT
GmbH). Three representative CT datasets from patients with
different breast sizes (small, medium, large) were chosen to
create 3D printable surface models.
3D printed breast models
To create a 3D printable hollow breast model, the breast image
files in digital imaging and communications medicine
(DICOM) format of the CT datasets were transferred to 3D
reconstruction software (Mimics inPrint 3.0, Materialise). The
surface models of the three breasts were printed by a 3D print-
er (Stratasys F370, alphacam swiss GmbH). The machine
used ABS Ivory, a high-strength material, for 3D-printing.
To hold structures in place, the 3D printer used support mate-
rial which was washed away by immersing the models into a
lye bath after being printed. The measured filling volumes for
the different breasts were small (248 ml), medium (358 ml),
and large (1067 ml). Figure 1 shows the 3D printed hollow
models.
Tissue phantom (filling)
To imitate different breast densities, emulsions of a 1.5% agar
solution (Bacto Agar, Becton Dickinson) and generally avail-
able plant oil (containing rapeseed oil and soy oil) were gen-
erated. Thereby, the agar solution represented the
fibroglandular breast tissue whereas plant oil represented fatty
tissue. In total, 30 g of soy lecithin (DAS gesunde PLUS, dm-
drogerie markt GmbH + Co) dissolved in 250 ml of water was
used as an emulsifier.
Four emulsions of 1 l each were generated representing the
four different types of the American College of Radiology
(ACR) classification (4th edition) which categorizes the breast
density based on the estimated percentage of fibroglandular
tissue compared to the whole breast as follows: 1, < 25%
glandular density; 2, 25–50% glandular density; 3, 51–75%
glandular density; and 4, > 75% glandular density. For our
mixtures, we chose the mean value of each category respec-
tively: 1, 12.5% Agar; 2, 37.5% Agar; 3, 62.5% Agar; 4,
87.5% Agar. The exact amounts of the agar and oil are de-
scribed in Table 1.
Phantom scans
Examinations were performed placing the phantoms in a ded-
icated spiral B-CT system (nu:view, AB-CT – Advanced
Breast-CT GmbH). The phantoms were hung up on a holding
device to ensure their complete display on the CT-images.
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Appendix 6 shows an example of a CT image of high and low
breast tissue density in two different patients who signed in-
formed consent for the scientific evaluation of the data in a
prospective study, which was approved by the local ethics
committee.
The spiral B-CT system is equipped with a photon-
counting detector with a cadmium telluride (CdTe) sensor
resulting in a detector pixel size of (0.1 mm)2 and a total
detector area of 280 × 50 mm2. The maximum field of mea-
surement has a diameter of 200 mm and a length of 160 mm
whereby the scanned length can be selected from three levels
(80, 120, or 160 mm). The acquisition time varies according to
the chosen field length (7–12 s) and is adjusted automatically,
depending on the scan length.
To achieve sufficient contrast for the visibility of
microcalcifications, the X-ray tube voltage is fixed at 60 kV.
The tube current can be selected from 10 values between 5 and
125 mA (6, 12.5, 25, 32, 40, 50, 64, 80, 100, or 125 mA).
More acquisition parameters of the B-CT are reported in
Table 2. Two modes exist for data acquisition: the “HighRes
(HR)” acquisition mode achieves higher spatial resolution
than the second “Standard (STD)” acquisition mode, however
thereby reducing SNR (due to the smaller voxel size) [12].
Each of the three phantoms consequently filled with the four
Fig. 1 3D printed breast
phantoms, ap and lateral view
Table 1 Composition of oil agar
emulsions Components Mixture 1, 87.5% fat Mixture 2, 62.5% fat Mixture, 3 37.5% fat Mixture 4,
12.5% fat
1.5% agar solution 119 ml 356 ml 594 ml 831 ml
Plant oil 831 ml 594 ml 356 ml 119 ml
Lecithin solution 50 ml 50 ml 50 ml 50 ml
Total 1 l 1 l 1 l 1 l
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different mixtures was scanned in HR mode at all 10 possible
tube current values resulting in a total of 120 scans.
Evaluation
Image analysis was performed on a PACS clinical workstation
using radiographic imaging display software (AGFA Impax
6). DICOM image data were imported to PACS and recon-
structed to 0.15-mm coronal slices (high-resolution
reconstruction, HR) and 0.3-mm coronal slices (standard re-
construction, STD) using a filtered back-projection recon-
struction algorithm. Qualitative image quality was assessed
regarding complete depiction of the phantom, and presence
of imaging artifacts or air bubbles in the agar-oil emulsion,
which was done by one single reader.
Quantitative image quality was evaluated by computation
of signal-to-noise ratios (SNR). Thereby, the average
Hounsfield unit (HU) of the homogeneous mixture (μmix)
was measured placing “regions of interest” (ROIs) of different
sizes (> 1000 mm2 for the large, > 500 mm2 for the medium,
and > 200 mm2 for the small breast) in areas with minimal air
bubbles avoiding imaging artifacts. The average HU in the
background was measured in the same way (μair, ROI size
150–200 mm2). ROIs were placed to the same locations on
the images reconstructed applying HR or STD reconstruction
modes. To obtain the SNR, the signal difference between the
homogeneous mixture and the surrounding air was divided by
the standard deviation of the background (σair) for both recon-
struction methods using Eq. 1. The standard deviation of the
SNR was calculated using error propagation according to Eq.
2 measuring in the datasets of the tube current of 25, 32, and
40 mA on three different slices; all other SNR values were















Evaluation of average dose by MC simulation
3D dose distributions were obtained using a commercially
available MC simulation (AB-CT – Advanced Breast-CT
GmbH) based on ImpactMC [13–15]. The phantom was seg-
mented from the surrounding air based on a thresholding
method and considered as a homogeneous breast tissue mate-
rial in the corresponding breast compositions.
The following scan parameters were applied in the MC
simulation: spiral mode, 2-s rotation time, 2000 projections
per rotation, 31.53-mm collimation length, and a pitch of
1.05. Total acquisition time depends on the object’s length
and equals to 7 s, 9.5 s, and 12 s for 8-, 12-, and 16-cm scan
length, respectively. The tube voltage was set at 60 kVp and
the tube current was varied at 6, 12.5, 25, 32, 40, 50, 64, 80,
100, and 125 mA. The X-ray tube’s anode angle was 10°, and
a beryllium and aluminum filter was applied.
1.0E6 photon histories were calculated for each MC simu-
lation. The average dose in the breast phantom’s volume was
acquired from the dose distribution calculated by the MC sim-
ulation. The dose calculation was conducted on the 3D breast
image reconstructed in STD mode.
Validation of the Monte Carlo simulation by dose
measurements using meta-oxide-semiconductor
field-effect transistor sensors
The dose measurements were performed by meta-oxide-
semiconductor field-effect transistor (MOSFET) sensors
(BMC MOSFETs TN-502RD-H, Best Medical) on the 3D
printed breast phantom. The MOSFET sensors measured the
local surface dose of the phantom during the scans in the HR
acquisition mode. 3D dose distributions over the phantoms
were obtained using the MC simulation. The measured and
simulated doses were then compared to validate the MC
simulation.
Results
Subjective image quality evaluation
Regularly, ring artifacts were present in the scans taken with
tube currents 25 mA and above, becoming stronger with in-
creasing tube current values. However, in all scans, a signifi-
cant influence of the ring artifacts on the quantitative evalua-
tion could be avoided due to manual ROI placement between
rings. Air bubbles were present in all the scans but areas with
only minimal air were available for all measurements.
Table 2 B-CT parameters
X-ray tube current 5–125 mA
X-ray tube voltage 60 kV
Data acquisition rate Up to 1000 Hz
Number of projections Up to 2000 per 360°
Number of reconstruction images* STD 313–589; HR 626–1178
Reconstruction field of measurement 200 × 80–160 mm
Acquisition time* 7 s (small, medium), 12 s (large)
STD, standard reconstruction; HR, high-resolution reconstruction
*Depending on the scan length
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Objective image quality evaluation
SNR of the phantoms at the different tube current values of HR
and STD reconstructions are reported inAppendices 3, 4, and 5.
Overall SNR values were higher in STD reconstructions than in
HR reconstructions. A logarithmic regression was applied to
describe the correlation between tube current and SNR as
depicted in Fig. 2. In the range from 25 to 50 mA, a
Fig. 2 Logistic regression curves
of SNR for different breast sizes
and compositions
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pseudolinear relation between the tube current and the SNR
was identified, whereas, with tube currents larger than 64 mA,
the SNR increase showed a saturation behavior. By increasing
the tube current to levels above 64 mA, no substantial increase
of the image quality could be achieved. Figure 3 shows the
diagrams for the three clinically most important tube current
settings (25, 32, and 40 mA) from top to bottom, high-
resolution (HR), and standard-resolution (STD) on the right
side. SNR increases with increasing density of the mixture,
whereas no clear correlation between SNR and phantom size
can be identified. An example plot of the noise as a function of
the mean signal value is provided in Fig. 4.
Validation of the Monte Carlo calculations: surface
dose comparison with MOSFET
The local surface doses obtained from 3D dose calculations of
the MC program exhibited an acceptable difference to the
surface doses measured by the MOSFETs (see Table 3). The
Fig. 3 Bar plots displaying mean SNR for different breast sizes and densities
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difference between the measured and the calculated dose was
less than 23% for each measurement.
Dose distribution
Appendix 7 shows a typical example of a dose distribution in
the different phantoms calculated by MC simulation. Due to
spiral CT scanning, the dose distribution of each transactional
slide shows an asymmetric dose distribution. The peripheries
are more irradiated than the center due to the high X-ray at-
tenuation at the peripheries. As the X-ray beam travels a great-
er distance in the large compared to the small breast and,
therefore, is more attenuated, the dose fall-off is greater in
the large breast phantom, which leads to lower dose at the
center for the large phantom compared to the smaller phan-
tom. The effect of the dose attenuation at the periphery is
demonstrated in Appendix 2 where line plots of the transac-
tional absorbed dose distributions calculated in the MC simu-
lation are presented.
Average absorbed dose as a function of breast size
and glandularity
The average dose over the breast is smaller for the large breast
than the small breast as a result of the dose distribution. The
average absorbed doses calculated by MC simulation are pre-
sented in Fig. 5.
The simulated average absorbed dose over the breast as a
function of breast volume and glandularity at 25 mA of X-ray
tube current is demonstrated in Fig. 6. The average absorbed
dose exhibits an exponential behavior depending on the breast
size and a linear correlation to the glandularity of the breast (p
< 0.05). The resulting values of the average absorbed dose
from the simulation and regression at 25 mA of X-ray tube
current are presented in Appendix 1. Reflecting the linear
correlation of the dose to the X-ray tube current, the average
absorbed dose equation is acquired as a function of the dose
factor derived for each breast volume and glandularity of 3D
phantoms and the mixture fillings in Eq. 3. F(breast volume,
glandularity) denotes the dose factor as a function of breast
volume and glandularity, and it denotes the X-ray tube cur-
rent. The lookup table of the factors is presented in Table 4.
Average absorbed dose
¼ F breast volume; glandularityð Þ  I ð3Þ
Optimization of acquisition parameters regarding
image quality and dose
SNR values ≥ 35 (HR) and ≥ 100 (STD) offer sufficient image
quality for clinical evaluation and were set as minimum
values. Table 5 shows which tube current should be selected
to achieve a reasonable image quality at the dose below 6.5
mGy. In order to get sufficient image quality, the dose limit for
the small breast phantom had to be increased to 7 mGy.
Discussion
The average absorbed dose of breasts for the optimal image
quality decreases with decreasing breast size for the same
breast density and increases with increasing breast density.
SNR increases with breast density; however, no systematic
dependence of SNR on breast size for the same X-ray tube
current was found. Individual adjustment of the tube current
according to patient’s characteristics allows to obtain images
of suitable quality while keeping sufficient control of the ap-
plied dose levels.
Compared to conventional mammography systems, scan
parameters in spiral B-CT need to be manually chosen before
the examination is performed. It is known that both absorbed
dose and image quality depend on individual patient charac-
teristics such as breast size and density. Therefore, it is impor-
tant to know in advance which tube current results in an image
Fig. 4 Plot shows the noise as a function of the signal intensity for the
large phantom and all 4 solutions. For each solution, 10 measurement
points are depicted corresponding to the 10 different tube currents. The
highest noise value for each solution corresponds to the lowest tube
current. It can be seen that both noise and signal increase with
decreasing tube current
Table 3 Comparison of measured and calculated surface doses for
validation of the MC simulation
MOSFET measurement MC simulation Difference
(mGy) (mGy) (%)
Large 10.0 ± 0.77 8.6 ± 1.01 - 13.7 ± 6.26
Medium 6.8 ± 0.35 8.0 ± 0.80 18.1 ± 8.41
Small 7.2 ± 0.50 6.7 ± 0.37 - 7.7 ± 1.40
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stack of optimum quality at the lowest possible dose depend-
ing on the previously mentioned patient characteristics. From
our recommendation table for B-CT examinations, it can be
seen that dose levels can be kept between 5.2 and 7.3 mGy for
all breast densities and breast size with the highest dose levels
obtained in small breasts with low density.
In cone-beam B-CT, usually two orthogonal low-dose
scout images of the breast are obtained before image ac-
quisition to set the optimal tube current. To keep the radi-
ation dose as low as possible, no scout images are acquired
in the spiral B-CT; therefore, the tube current has to be set
before image acquisition. Both cone-beam and spiral B-CT
offer the possibility to acquire true 3D datasets. In contrast
to cone-beam B-CT, which achieves a lower spatial reso-
lution than DM, spiral B-CT offers a resolution of better
than 100 μm for both in-plane and z-resolution with a
better depiction of microcalcifications [10, 16].
Our study has shown that by varying the tube current de-
pending on breast density and size, sufficient image quality
can be achieved at dose levels similar to DM. Thereby, the
SNR is more dependent on the breast density than on breast
volume. The average dose over the breast is higher for the
smaller breast than for the larger due to the relatively higher
surface area compared to the total volume. The surface area
receives higher dose than the inner part of the breast which is
relatively less in small breasts.
Meanwhile, most European countries implemented BC
screening programs using mammography which resulted in
a reduction of breast cancer (BC) mortality [2, 3]. However,
tissue overlapping or dense glandular tissue (ACR categories
c and d) can mask small tumors and thus reduce the sensitivity
of DM. Especially in women with dense breast tissue or breast
implants, the accuracy of mammography breast cancer screen-
ing is substantially reduced. Moreover, painful breast com-
pression is required for DM, which does not only lead to
patient discomfort but could also discourage women from
participating in screening programs [5, 6, 17]. The recently
introduced spiral B-CT system offers breast image acquisition
without painful compression. This might encourage women to
take part in BC screening programs in the future thus render-
ing screening programs more effective.
Several studies have shown very promising results re-
garding the use of dedicated spiral B-CT in the screening
and diagnosis of breast cancer. Several studies have shown
B-CT to be a good alternative to conventional mammogra-
phy in terms of both radiation dose and quality [11, 12, 18,
19]. In principle, dynamic scans after contrast-agent injec-
tion are possible. Scanning in STD mode, the dose could
keep at an acceptable level even after two or more acqui-
sitions. It has been demonstrated that even low-dose per-
fusion CT of the breast in a prone position is possible and
shows significant differences in breast lesions compared to
normal breast tissue [18, 20].
Fig. 5 Average absorbed dose in
mGy as a function of the X-ray
tube current
Fig. 6 Average absorbed dose as a function of breast volume and density
at 25-mA X-ray tube current
Table 4 Lookup table of radiation dose factor as a function of breast
volume and glandularity
F(breast volume, glandularity) (mGy/mA) Breast volume (cm3)
248 358 1067
Glandularity (%) 12.5 0.25 0.24 0.19
37.8 0.27 0.25 0.20
62.5 0.28 0.26 0.20
87.5 0.29 0.27 0.21
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One disadvantage of the current B-CT device is the rela-
tively long reconstruction time of the 3D datasets, which takes
approximately 20 min to be completed whereas DM images
are available immediately after acquisition. No scout images
are available, so that breast density cannot be assessed from
the B-CT before the scan is completed. Therefore, previously
available mammography is helpful for the choosing of the best
tube current setting. B-CT systems are known for limited cov-
erage of the axilla compared to DM. Therefore, patient posi-
tioning is extremely important and needs to be done carefully.
Additional sonographic evaluation can solve the problem of
the axilla extending glandular tissue [16, 19].
Our study has several limitations: Firstly, the data was ob-
tained using 3D printed phantoms filled with homogeneous
mixtures. Soft tissue lesions or microcalcifications were not im-
plemented in the phantoms. Therefore, the visibility of soft tis-
sue lesions or microcalcifications could not be assessed.
Secondly, validation of the Monte Carlo simulations was con-
ducted by measuring the surface dose of the phantoms using
MOSFET sensors; direct dose measurements within the phan-
toms were not performed. Thirdly, only three different breast
sizes were evaluated. However, a larger number of breast phan-
toms for each breast size would have added little further infor-
mation. Fourthly, the average dose instead of mean glandular
dose was calculated due to the homogeneous mixtures.
However, the average dosemay be used as aworst-case scenario
with mean glandular dose typically being smaller. The reason
for that is that the dose in the central parts is typically smaller
compared to the dose in the surface region of the breast [12].
Fifthly, we were not able to compute contrast-to-noise ratios in
dependence of the tube current or dose, which would have been
helpful for choosing the best tube current setting and for com-
parison to existing literature. This topic will be addressed in a
subsequent study requiring new 3D printed phantoms. Sixthly,
new reconstruction algorithms such as iterative reconstruction or
techniques based on deep learning may be advantageous com-
pared to filtered back-projection. However, the evaluation of
these new algorithms was out of the scope of this study.
Conclusion
In conclusion, adjusting the scan parameters in spiral B-CT
based on breast density and breast volume provides optimal
image quality at a reasonable dose, individually adapted to the
patient characteristics.
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